Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LLY vs GSK✓SelectedUSD · GSKLLY vs GSK performance historyLatest closeAs of-0.82%11/16
Stock and ETF performance explorer

LLY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+2,064.5%
GSK return
+107.3%
Excess return
+1,957.2%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.8%-0.1%-0.7%-0.8%
7D+1.5%-1.3%+2.8%+2.2%
30D+14.0%+2.7%+11.3%+12.4%
3M+21.5%+2.7%+18.7%+19.8%
6M+42.8%+3.3%+39.5%+40.3%
YTD+34.0%+6.5%+27.6%+29.5%
1Y+40.5%+10.7%+29.8%+33.0%
3Y+148.1%+64.4%+83.7%+86.7%
5Y+480.1%+46.7%+433.4%+355.2%
10Y+2,064.5%+109.4%+1,955.1%+1,182.4%
All+2,064.5%+107.3%+1,957.2%+1,182.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling